| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 |
|---|---|---|---|---|---|---|---|---|---|---|
Operating activities | ||||||||||
Net Income (Loss) Attributable to Parent | ||||||||||
322 | 300 | 197 | 155 | 144 | 136 | 121 | 120 | 76 | 37 | 24 |
Adjustments to reconcile net income/(loss) to net cash provided by operating activities: | ||||||||||
Provision for credit losses | ||||||||||
75 | 87 | 44 | 77 | 53 | 22 | 19 | 11 | 28 | 53 | 43 |
Deferred Income Tax Expense (Benefit) | ||||||||||
10 | -6 | 31 | -2 | -3 | -3 | -11 | -3 | -6 | -5 | -8 |
Depreciation and amortization | ||||||||||
37 | 32 | 27 | 21 | 16 | 14 | 11 | 9 | 9 | 6 | 7 |
Net (gain)/loss on sale of loans held for sale | ||||||||||
-20 | -15 | -2 | 2 | -0 | 0 | 0 | 0 | 0 | -0 | -1 |
Increase (decrease) in valuation allowance on mortgage servicing rights | ||||||||||
5 | -2 | 2 | 0 | 0 | - | -0 | -0 | -0 | -0 | -0 |
Bank owned life insurance (BOLI) income | ||||||||||
- | - | - | - | 2 | 2 | 1 | 2 | 2 | 1 | 1 |
Stock-based compensation expense | ||||||||||
17 | 16 | 22 | 13 | 12 | 14 | 20 | 12 | 7 | 6 | 5 |
Tax benefit from stock option exercises | ||||||||||
- | - | - | - | - | - | - | - | 3 | 0 | 0 |
Excess tax benefits from stock-based compensation arrangements | ||||||||||
- | - | - | 2 | 1 | 2 | 1 | 7 | 8 | 1 | 0 |
Purchases and originations of loans held for sale | ||||||||||
10,183 | 6,753 | 5,556 | 3,327 | 127 | 0 | 0 | - | - | - | - |
Technology write-off | ||||||||||
- | - | - | 0 | 0 | - | - | - | - | - | - |
Other real estate owned write-down | ||||||||||
- | 6 | - | 0 | 0 | - | - | - | - | - | - |
Changes in operating assets and liabilities: | ||||||||||
Accrued interest receivable and other assets | ||||||||||
143 | 123 | 105 | 61 | 61 | 58 | -31 | 61 | 63 | 24 | 28 |
Accrued interest payable and other liabilities | ||||||||||
87 | -5 | 10 | -2 | -3 | 38 | 3 | 10 | 32 | 25 | -1 |
Net cash provided by operating activities of continuing operations | ||||||||||
- | - | - | - | - | - | - | - | 75 | -403 | -140 |
Net cash provided by operating activities of discontinued operations | ||||||||||
- | - | - | - | - | - | - | - | -0 | -0 | -0 |
Net cash provided by operating activities | ||||||||||
-240 | -679 | 132 | -726 | 68 | 157 | 191 | 89 | 75 | -403 | -140 |
Investing activities | ||||||||||
Purchases of investment securities | ||||||||||
113 | 101 | 97 | 1 | 0 | 0 | 0 | 0 | 10 | 0 | 0 |
Maturities and calls of available-for-sale securities | ||||||||||
0 | 0 | 94 | 0 | 2 | 11 | 15 | 14 | 8 | 4 | 32 |
Principal payments received on investment securities | ||||||||||
6 | 3 | 4 | 5 | 8 | 9 | 18 | 27 | 42 | 74 | 86 |
Originations of mortgage finance loans | ||||||||||
138,759 | 99,151 | 86,931 | 100,574 | 86,342 | 58,090 | 51,087 | 51,110 | 27,234 | 22,859 | 16,582 |
Proceeds from pay-offs of mortgage finance loans | ||||||||||
136,466 | 98,581 | 86,120 | 101,043 | 85,478 | 56,772 | 51,478 | 50,015 | 26,348 | - | - |
Net increase in loans held for investment, excluding mortgage finance loans | ||||||||||
-139 | 1,402 | 2,395 | 1,321 | 1,603 | 1,676 | 1,706 | 1,220 | 890 | 303 | 466 |
Proceeds from sale of mortgage servicing rights | ||||||||||
0 | 70 | 0 | 0 | - | - | 0 | - | - | - | - |
Proceeds from sales and repayments of loans held for sale | ||||||||||
9,508 | 5,759 | 5,457 | 2,405 | 40 | 0 | 0 | - | - | 22,359 | 16,399 |
Purchase of premises and equipment, net | ||||||||||
16 | 7 | 12 | 2 | 5 | 15 | 4 | 3 | 3 | 3 | 4 |
Proceeds from sale of other real estate owned, net | ||||||||||
0 | 13 | 1 | 0 | 1 | 5 | 11 | 14 | 23 | 5 | 12 |
Cash paid for acquisition | ||||||||||
- | - | - | - | - | - | 2 | 0 | 11 | 10 | 0 |
Net cash provided by/(used in) investing activities | ||||||||||
-2,276 | -1,992 | -3,215 | -850 | -2,460 | -2,983 | -1,275 | -2,263 | -1,727 | -232 | -339 |
Financing activities | ||||||||||
Net increase in deposits | ||||||||||
5,872 | 1,482 | 2,106 | 1,932 | 2,411 | 3,415 | 1,816 | 1,884 | 100 | 1,334 | 787 |
Costs from issuance of stock related to stock-based awards and warrants | ||||||||||
1 | 2 | 2 | 2 | 1 | 2 | 2 | 0 | 2 | 0 | 1 |
Net proceeds from issuance of common stock | ||||||||||
- | - | - | 236 | 0 | 256 | 0 | 86 | 0 | 12 | 59 |
Net proceeds from issuance of preferred stock | ||||||||||
- | - | - | - | - | - | 144 | 0 | 0 | - | 75 |
Preferred dividends paid | ||||||||||
9 | 9 | 9 | 9 | 9 | 9 | 6 | 0 | - | - | - |
Preferred stock dividend and accretion of preferred stock discount | ||||||||||
- | - | - | - | - | - | - | - | - | - | -1 |
Repurchase of preferred stock | ||||||||||
- | - | - | - | - | - | - | - | - | - | 75 |
Proceeds from (Repayments of) Short-term Debt | ||||||||||
-1,500 | 1,100 | 800 | 500 | 399 | 244 | -797 | 318 | 1,341 | -362 | -553 |
Excess tax benefits from stock-based compensation arrangements | ||||||||||
- | - | - | 2 | 1 | 2 | 1 | 7 | 8 | 1 | 0 |
Net increase/(decrease) in federal funds purchased and repurchase agreements | ||||||||||
499 | -276 | -255 | 33 | -50 | 77 | 124 | 139 | -128 | 296 | -230 |
Issuance of subordinated notes | ||||||||||
- | - | - | - | - | 172 | 0 | 111 | 0 | 0 | - |
Net cash provided by/(used in) financing activities | ||||||||||
3,861 | 2,846 | 3,149 | 2,624 | 2,852 | 4,002 | 1,032 | 2,269 | 1,582 | 690 | 523 |
Cash and Cash Equivalents, Period Increase (Decrease) | ||||||||||
1,345 | 174 | 66 | 1,048 | 460 | 1,176 | -52 | 95 | -69 | 54 | 43 |
Supplemental disclosures of cash flow information: | ||||||||||
Cash paid during the period for interest | ||||||||||
393 | 236 | 115 | 63 | 46 | 33 | 24 | 21 | 20 | 38 | 50 |
Cash paid during the period for income taxes | ||||||||||
89 | 75 | 103 | 88 | 87 | 74 | 77 | 69 | 32 | 27 | 14 |
Non-cash transactions: | ||||||||||
Transfers from loans/leases to other real estate owned and other repossessed assets | ||||||||||
- | - | - | 18 | 1 | 0 | 1 | 3 | 24 | 29 | 23 |